Cargando…

Changes of Ocular Dimensions as a Marker of Disease Progression in a Murine Model of Pigmentary Glaucoma

PURPOSE: The elevation of intraocular pressure (IOP), a major risk factor in glaucoma, is an important parameter tracked in experimental models of this disease. However, IOP measurement in laboratory rodents is challenging and may not correlate with some key pathological events that occur in the dev...

Descripción completa

Detalles Bibliográficos
Autores principales: Fiedorowicz, Michał, Wełniak-Kamińska, Marlena, Świątkiewicz, Maciej, Orzeł, Jarosław, Chorągiewicz, Tomasz, Toro, Mario Damiano, Rejdak, Robert, Bogorodzki, Piotr, Grieb, Paweł
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7500411/
https://www.ncbi.nlm.nih.gov/pubmed/33013417
http://dx.doi.org/10.3389/fphar.2020.573238
_version_ 1783583857218420736
author Fiedorowicz, Michał
Wełniak-Kamińska, Marlena
Świątkiewicz, Maciej
Orzeł, Jarosław
Chorągiewicz, Tomasz
Toro, Mario Damiano
Rejdak, Robert
Bogorodzki, Piotr
Grieb, Paweł
author_facet Fiedorowicz, Michał
Wełniak-Kamińska, Marlena
Świątkiewicz, Maciej
Orzeł, Jarosław
Chorągiewicz, Tomasz
Toro, Mario Damiano
Rejdak, Robert
Bogorodzki, Piotr
Grieb, Paweł
author_sort Fiedorowicz, Michał
collection PubMed
description PURPOSE: The elevation of intraocular pressure (IOP), a major risk factor in glaucoma, is an important parameter tracked in experimental models of this disease. However, IOP measurement in laboratory rodents is challenging and may not correlate with some key pathological events that occur in the development of glaucoma. The aims of this study were to quantify changes in ocular morphology in DBA/2J mice that develop spontaneous, age-dependent, pigmentary glaucoma and to check the possible correlation of these parameters with IOP. METHOD: Eye morphology was evaluated with MRI in DBA/2J, DBA/2J-Gpnmb(+)/SjJ, and C57BL/6J female mice ages 3, 6, 9, 12, and 15 months. The animals were anesthetized with isoflurane. A planar receive-only surface coil (inner diameter = 10 mm) was placed over each animal’s left eye and the image was acquired with a 7T small animal-dedicated magnetic resonance tomograph and T2-weighted TurboRARE sequence. Ocular dimensions were manually quantitated using OsiriX software. IOP was measured with rebound tonometry. RESULTS: In the control animals, no age-related changes in the ocular morphology were noted. Since 6 months of age, the anterior chamber deepening and elongation of the eyeballs of DBA/2J mice was detectable. We found a significant, positive correlation between IOP and axial length, anterior chamber area, or anterior chamber width in C57BL/6J mice but not in DBA/2J mice. However, after excluding the measurements performed in the oldest DBA/2J mice (i.e. analyzing only the animals ages 3 to 12 months), we demonstrated a significant positive correlation between IOP and anterior chamber width. CONCLUSION: High-resolution magnetic resonance imaging of the eye area in mice enables reproducible and consistent measures of key dimensions of the eyeball. We observed age-dependent alterations in the eye morphology of DBA/2J mice that mostly affected the anterior chamber. We also demonstrated a correlation between some of the ocular dimensions and the IOP of C57Bl/6J mice and DBA/2J mice with moderately advanced glaucomatous pathology.
format Online
Article
Text
id pubmed-7500411
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-75004112020-10-02 Changes of Ocular Dimensions as a Marker of Disease Progression in a Murine Model of Pigmentary Glaucoma Fiedorowicz, Michał Wełniak-Kamińska, Marlena Świątkiewicz, Maciej Orzeł, Jarosław Chorągiewicz, Tomasz Toro, Mario Damiano Rejdak, Robert Bogorodzki, Piotr Grieb, Paweł Front Pharmacol Pharmacology PURPOSE: The elevation of intraocular pressure (IOP), a major risk factor in glaucoma, is an important parameter tracked in experimental models of this disease. However, IOP measurement in laboratory rodents is challenging and may not correlate with some key pathological events that occur in the development of glaucoma. The aims of this study were to quantify changes in ocular morphology in DBA/2J mice that develop spontaneous, age-dependent, pigmentary glaucoma and to check the possible correlation of these parameters with IOP. METHOD: Eye morphology was evaluated with MRI in DBA/2J, DBA/2J-Gpnmb(+)/SjJ, and C57BL/6J female mice ages 3, 6, 9, 12, and 15 months. The animals were anesthetized with isoflurane. A planar receive-only surface coil (inner diameter = 10 mm) was placed over each animal’s left eye and the image was acquired with a 7T small animal-dedicated magnetic resonance tomograph and T2-weighted TurboRARE sequence. Ocular dimensions were manually quantitated using OsiriX software. IOP was measured with rebound tonometry. RESULTS: In the control animals, no age-related changes in the ocular morphology were noted. Since 6 months of age, the anterior chamber deepening and elongation of the eyeballs of DBA/2J mice was detectable. We found a significant, positive correlation between IOP and axial length, anterior chamber area, or anterior chamber width in C57BL/6J mice but not in DBA/2J mice. However, after excluding the measurements performed in the oldest DBA/2J mice (i.e. analyzing only the animals ages 3 to 12 months), we demonstrated a significant positive correlation between IOP and anterior chamber width. CONCLUSION: High-resolution magnetic resonance imaging of the eye area in mice enables reproducible and consistent measures of key dimensions of the eyeball. We observed age-dependent alterations in the eye morphology of DBA/2J mice that mostly affected the anterior chamber. We also demonstrated a correlation between some of the ocular dimensions and the IOP of C57Bl/6J mice and DBA/2J mice with moderately advanced glaucomatous pathology. Frontiers Media S.A. 2020-09-04 /pmc/articles/PMC7500411/ /pubmed/33013417 http://dx.doi.org/10.3389/fphar.2020.573238 Text en Copyright © 2020 Fiedorowicz, Wełniak-Kamińska, Świątkiewicz, Orzeł, Chorągiewicz, Toro, Rejdak, Bogorodzki and Grieb http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Fiedorowicz, Michał
Wełniak-Kamińska, Marlena
Świątkiewicz, Maciej
Orzeł, Jarosław
Chorągiewicz, Tomasz
Toro, Mario Damiano
Rejdak, Robert
Bogorodzki, Piotr
Grieb, Paweł
Changes of Ocular Dimensions as a Marker of Disease Progression in a Murine Model of Pigmentary Glaucoma
title Changes of Ocular Dimensions as a Marker of Disease Progression in a Murine Model of Pigmentary Glaucoma
title_full Changes of Ocular Dimensions as a Marker of Disease Progression in a Murine Model of Pigmentary Glaucoma
title_fullStr Changes of Ocular Dimensions as a Marker of Disease Progression in a Murine Model of Pigmentary Glaucoma
title_full_unstemmed Changes of Ocular Dimensions as a Marker of Disease Progression in a Murine Model of Pigmentary Glaucoma
title_short Changes of Ocular Dimensions as a Marker of Disease Progression in a Murine Model of Pigmentary Glaucoma
title_sort changes of ocular dimensions as a marker of disease progression in a murine model of pigmentary glaucoma
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7500411/
https://www.ncbi.nlm.nih.gov/pubmed/33013417
http://dx.doi.org/10.3389/fphar.2020.573238
work_keys_str_mv AT fiedorowiczmichał changesofoculardimensionsasamarkerofdiseaseprogressioninamurinemodelofpigmentaryglaucoma
AT wełniakkaminskamarlena changesofoculardimensionsasamarkerofdiseaseprogressioninamurinemodelofpigmentaryglaucoma
AT swiatkiewiczmaciej changesofoculardimensionsasamarkerofdiseaseprogressioninamurinemodelofpigmentaryglaucoma
AT orzełjarosław changesofoculardimensionsasamarkerofdiseaseprogressioninamurinemodelofpigmentaryglaucoma
AT choragiewicztomasz changesofoculardimensionsasamarkerofdiseaseprogressioninamurinemodelofpigmentaryglaucoma
AT toromariodamiano changesofoculardimensionsasamarkerofdiseaseprogressioninamurinemodelofpigmentaryglaucoma
AT rejdakrobert changesofoculardimensionsasamarkerofdiseaseprogressioninamurinemodelofpigmentaryglaucoma
AT bogorodzkipiotr changesofoculardimensionsasamarkerofdiseaseprogressioninamurinemodelofpigmentaryglaucoma
AT griebpaweł changesofoculardimensionsasamarkerofdiseaseprogressioninamurinemodelofpigmentaryglaucoma